Retroviral Immunotoxin Gene Therapy of Leukemia in Mice Using Leukemia-Specific T Cells Transduced with an Interleukin-3/Bax Fusion Protein Gene

Human Gene Therapy

Volumn 14, Issue 18, 2003, Pages 1787-1798

  Vallera, Daniel A ^a   Jin, N I ^a   Shu, Yanqun ^a   Panoskaltsis Mortari, Angela ^b   Kelekar, Ameeta ^c   Chen, Wei ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Div of Bone Marrow Transplantation   (United States)

^c Mayo Memorial Building   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN; IMMUNOTOXIN; INTERLEUKIN 3; PROTEIN BAX; PROTEIN BCL 2; PSEUDOMONAS EXOTOXIN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; FUSION GENE; GENE TARGETING; GENE THERAPY; HUMORAL IMMUNITY; LEUKEMIA; MOUSE; NONHUMAN; RETROVIRUS; STEM CELL; T LYMPHOCYTE;

ANIMALIA; BACTERIA (MICROORGANISMS); PSEUDOMONAS; RNA VIRUSES; STAPHYLOCOCCUS PHAGE 3A; UNIDENTIFIED RETROVIRUS;

EID: 0347517727     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403322611791     Document Type: Article

References (50)

1. ADAMS, J.M., and CORY, S. (1998), The Bcl-2 protein family: Arbiters of cell survival. Science 281, 1322-1326.
2. ANTONSSON, B. CONTI, F., CIAVATTA, A., MONTESSUIT, S., LEWIS, S., MARTINOU, I., BERNASCONI, L., BERNARD, A., MERMOD, J.J., MAZZEI, G., MAUNDRELL, K., GAMBALE, F., SADOUL, R., and MARTINOU, J.C. (1997). Inhibition of Bax channel-forming activity by Bcl-2. Science 277, 370-372.
3. AQEILAN, R., YARKONI, S., and LORBERBOUM-GALSKI, H. (1999). Interleukin 2-Bax: A novel prototype of human chimeric proteins for targeted therapy. FEBS Lett. 457, 271-276.
4. ARAFAT, W.O., GOMEZ-NAVARRO, J., XIANG, J., BARNES, M.N., MAHASRESHTI, P., ALVAREZ, R.D., SIEGAL, G.P., BADIB, A.O., BUCHSBAUM, D., CURIEL, D.T., and STACKHOUSE, M.A. (2000). An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovariancancer. Mol. Ther. 1, 545-554.
5. BACCI, A., MONTAGNOLI, C., PERRUCCIO, K., BOZZA, S., GAZIANO, R., PITZURRA, L., VELARDI, A., D'OSTIANI, C.F., CUTLER, J.E., and ROMANI, L. (2002). Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J. Immunol. 168, 2904-2913.
6. BASANEZ, G., NECHUSHTAN, A., DROZHININ, O., CHANTURIYA, A., CHOE, E., TUTT, S., WOOD, K.A., HSU, Y., ZIMMERBERG, J., and YOULE, R.J. (1999). Bax, but not Bcl-xL, decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar concentrations. Proc. Natl. Acad. Sci. U.S.A. 96, 5492-5497.
7. BERKE, G. (1997). Killing mechanisms of cytotoxic lymphocytes. Curr. Opin. Hematol. 4, 32-40.
8. BLACK, J.H., MCCUBREY, J.A., WILLINGHAM, M.C., RAMAGE, J., HOGGE, D.E., and FRANKEL, A.E. (2003). Diphtheria toxin-interleukin-3 fusion protein (DT(388)IL-3) prolongs disease-free survival of leukemic immunocompromised mice. Leukemia 17, 155-159.
9. BRADNER, W.T., and PINDELL, M.H. (1966). Myloid leukemia C1498 as a screen for cancer chemotherapeutic agents. Cancer Chemother. Screening Data 43, 375-390.
10. CHAN, C.H., BLAZAR, B.R., GREENFIELD, L., KREITMAN, R.J., and VALLERA, D.A. (1996). Reactivity of murine cytokine fusion toxin, diphtheria toxin390-murine interleukin-3 (DT390-mIL-3), with bone marrow progenitor cells. Blood 88, 1445-1456.
11. CHEEVER, M.A., and CHEN, W. (1997). Therapy with cultured T cells: Principles revisited. Immunol. Rev. 157, 177-194.
12. CHEN, S.Y., ZANI, C., KHOURI, Y., and MARASCO, W.A. (1995). Design of a genetic immunotoxin to eliminate toxin immunogenicity. Gene Ther. 2, 116-123.
13. CHEN, S.Y., YANG, A.G., CHEN, J.D., KUTE, T., KING, C.R., COLLIER, J., CONG, Y., YAO, C., and HUANG, X.F. (1997). Potent antitumour activity of a new class of tumour-specific killer cells. Nature 385, 78-80.
14. CHEN, W., REESE, V.A., and CHEEVER, M.A. (1990). Adoptively transferred antigen-specific T cells can be grown and maintained in large numbers in vivo for extended periods of time by intermittent restimulation with specific antigen plus IL-2. J. Immunol. 144, 3659-3666.
15. COLL, J.L., NEGOESCU, A., LOUIS, N., SACHS, L., TENAUD, C., GIRARDOT, V., DEMEINEX, B., BRAMBILLA, E., BRAMBILLA, C., and FAVROT, M. (1998). Antitumor activity of Bax and p53 naked gene transfer in lung cancer: In vitro and in vivo analysis. Hum. Gene Ther. 9, 2063-2074.
16. COLLIER, R.J. (1975). Diphtheria toxin: Mode of action and structure. Bacteriol. Rev. 39, 54-85.
17. DONOVAN, J.J., SIMON, M.I., DRAPER, R.K., and MONTAL, M. (1981). Diphtheria toxin forms transmembrane channels in planar lipid bilayers. Proc. Natl. Acad. Sci. U.S.A. 78, 172-176.
18. DURHAM, L.J., and STEWART, H.L. (1953). A survey of transplantable and transmissible animal tumors. J. Natl. Cancer Inst. 13, 1299-1377.
19. FEURING-BUSKE M., FRANKEL A.E., ALEXANDER R.L., GERHARD B., and HOGGE D.E. (2002). A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors. Cancer Res. 62, 1730-1736.
20. FOSS, F.M., BORKOWSKI, T.A., GILLIOM, M., STETLER-STEVENSON, M., JAFFE, E.S., FIGG, W.D., TOMPKINS, A., BASTIAN, A., NYLEN, P., WOODWORTH, T., et al. (1994). Chimeric fusion protein toxin DAB486IL-2 in advanced mycosis fungoides and the Sezary syndrome: Correlation of activity and interleukin-2 receptor expression in a phase II study. Blood 84, 1765-1774.
21. GROSS, A., JOCKEL J., WEI, M.C., and KORSMEYER, S.J. (1998). Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17, 3878-3885.
22. HAINAUT, P. (1995). The tumor suppressor protein p53: A receptor to genotoxic stress that controls cell growth and survival. Curr. Opin. Oncol. 7, 76-82.
23. HONJO, T., NISHIZUKA, Y., and HATAISHI, O. (1968). Diphtheria toxin-dependent adenosine diphosphate ribosylation of aminoacyl transferase II and inhibition of protein synthesis. J. Biol. Chem. 243, 3553-3555.
24. HSU, Y.T., WOLTER, K.G., and YOULE, R.J. (1997). Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc. Natl. Acad. Sci. U.S.A. 94, 3668-3672.
25. ICHINOSE, M., LIU, X.H., HAGIHARA, N., and YOULE, R.J. (2002). Extracellular Bad fused to toxin transport domains induces apoptosis. Cancer Res. 62, 1433-1438.
26. JACOBSON, M.D., WEIL, M., and RAFF, M.C. (1997). Programmed cell death in animal development. Cell 88, 347-354.
27. JIN, N., CHEN, W., BLAZAR, B.R., RAMAKRISHNAN, S., and VALLERA, D.A. (2002). Gene therapy of murine solid tumors with T cells transduced with a retroviral vascular endothelial growth factor-immunotoxin target gene. Hum. Gene Ther. 13, 497-508.
28. KAGAN, B.L., FINKELSTEIN, A., and COLOMBINI, M. (1981). Diphtheria toxin fragment forms large pores in phospholipid bilayer membranes. Proc. Natl. Acad. Sci. U.S.A. 78, 4950-4954.
29. LI, C., HALL, W.A., JIN, N., TODHUNTER, D.A., PANOSKALTSIS-MORTARI, A., and VALLERA, D.A. (2002). Targeting glioblastoma multiforme with an IL-13/diphtheria toxin fusion protein in vitro and in vivo in nude mice. Protein Eng. 15, 419-427.
30. MAINE, G.N., and MULE, J.J. (2002). Making room for T cells. J. Clin. Invest. 110, 185-192.
31. MUCHMORE, S.W., SATTLER, M., LIANG, H., MEADOWS, R.P., HARLAN, J.E., YOON, H.S., NETTESHEIM, D., CHANG, B.S., THOMPSON, C.B., WONG, S.L., NG, S.L., and FESIK, S.W. (1996). X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381, 335-341.
32. MURPHY, J.R., and VANDERSPEK, J.C. (1995). Targeting diphtheria toxin to growth factor receptors. Semin. Cancer Biol. 6, 259-267.
33. OLTVAI, Z.N., MILLIMAN, C.L., and KORSMEYER, S.J. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619.
34. PARDOLL, D., and TOPALIAN, S.L. (1998). The role of CD4+ T cell responses in antitumor immunity. Curr. Opin. Immunol. 10, 588-594.
35. RAPOPORT, T.A., ROLLS, M., and JUNGNICKEL, B. (1996). Approaching the mechanism of protein transport across the ER membrane. Curr. Opin. Cell Biol. 8, 499-504.
36. SAKAGUCHI S., SAKAGUCHI, N., ASANO, M., ITOH, M., and TODA, M. (1995). Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164.
37. SCHLESINGER, P.H., GROSS, A., YIN, X.M., YAMAMOTO, K., SAITO, M., WAKSMAN, G., and KORSMEYER, S.J. (1997). Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc. Natl. Acad. Sci. U.S.A. 94, 11357-11362.
38. SHINOURA, N., YAMAMOTO, N., ASAI, A., KIRINO, T., and HAMADA, H. (2000) Adenovirus-mediated transfer of Fas ligand gene augments radiation-induced apoptosis in U-373MG glioma cells. Jpn. J. Cancer. Res. 91, 1044-1050.
39. SURI-PAYER, E., AMAR, A.Z., THORNTON, A.M., and SHEVACH, E.M. (1998). CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160, 1212-1218.
40. 388IL-3 for phase I clinical trials. Prot. Expr. Purif. (in press).
41. VALLERA, D.A., SEO, S.Y., PANOSKALTSIS-MORTARI, A., GRIFFIN, J.D., and BLAZAR, B.R. (1999). Targeting myeloid leukemia with a DT(390)-mIL-3 fusion immunotoxin: Ex vivo and in vivo studies in mice. Protein Eng. 12, 779-785.
42. VALLERA, D.A., JIN, N., BALDRICA, J.M., PANOSKALTSIS-MORTARI, A., CHEN, S.Y., and BLAZAR, B.R. (2000). Retroviral immunotoxin gene therapy of acute myelogenous leukemia in mice using cytotoxic T cells transduced with an interleukin 4/diphtheria toxin gene. Cancer Res. 60, 976-984.
43. VALLERA, D.A., LI, C., JIN, N., PANOSKALTSIS-MORTARI, A., and HALL, W.A. (2002). Targeting urokinase-type plasminogen activator receptor on human glioblastoma tumors with diphtheria toxin fusion protein DTAT. J. Natl. Cancer Inst. 94, 597-606.
44. VAUX, D.L., HEACKER, G., and STRASSER, A. (1994). An evolutionary perspective on apoptosis. Cell 76, 777-779.
45. WALTER, P., and JOHNSON, A.E. (1994). Signal sequence recognition and protein targeting to the endoplasmic reticulum membrane. Annu. Rev. Cell Biol. 10, 87-119.
46. WANG, J., SAFFOLD, S., CAO, X., KRAUSS, J., and CHEN, W. (1998). Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. J. Immunol. 161, 5516-5524.
47. WOLTER, K.G., HSU, Y.T., SMITH, C.L., NECHUSHTAN, A., XI, X.G., and YOULE, R.J. (1997). Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139, 1281-1292.
48. YEE, C., RIDDELL, S.R., and GREENBERG, P.D. (1997). Prospects for adoptive T cell therapy. Curr. Opin. Immunol. 9, 702-708.
49. ZHAN, H., OH, K.J., SHIN, Y.K., HUBBELL, W.L., and COLLIER, R.J. (1995). Interaction of the isolated transmembrane domain of diphtheria toxin with membranes. Biochemistry 34, 4856-4863.
50. ZHANG, Y., LOUBOUTIN, J.P., ZHU, J., RIVERA, A.J., and EMERSON, S.G. (2002). Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. J. Clin. Invest. 109, 1335-1344.